Jpmorgan Chase & Co »

Travere Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $12k 200 58.30
2024-12-31 $103k 5.9k 17.42
2024-03-31 $540k 70k 7.71
2023-12-31 $629k 70k 8.99

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Travere Therapeutics

IMC-Chicago
Group One Trading
Simplex Trading
Hrt Financial
Jpmorgan Chase & Co

View all funds holding Travere Therapeutics